About the bill
H.R. 5687 directs the Food and Drug Administration (FDA) to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II or III opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to inactivate immediately or render unattractive unused drugs. In addition, this bill will facilitate utilization of packaging that may reduce overprescribing, diversion, or abuse of opioids. Finally, the bill will require the Government Accountability Office (GAO) to study new and innovative technologies that claim to be able to ...
Sponsor and status
Sponsor. Representative for North Carolina's 8th congressional district. Republican.
Last Updated: Jun 20, 2018
Length: 12 pages
H.R. 5687 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2018). H.R. 5687 — 115th Congress: SOUND Disposal and Packaging Act. Retrieved from https://www.govtrack.us/congress/bills/115/hr5687
“H.R. 5687 — 115th Congress: SOUND Disposal and Packaging Act.” www.GovTrack.us. 2018. September 21, 2018 <https://www.govtrack.us/congress/bills/115/hr5687>
SOUND Disposal and Packaging Act, H.R. 5687, 115th Cong. (2018).
|title=H.R. 5687 (115th)
|accessdate=September 21, 2018
|author=115th Congress (2018)
|date=May 7, 2018
|quote=SOUND Disposal and Packaging Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.